An abnormal Pap smear and the impact of notification manner on women’s health-related quality of life, coping and awareness of human papillomavirus

Notification of an abnormal Pap smear: An intervention study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN80102009

Enrollment

235

Registered

2018-01-02

Start date

2016-02-01

Completion date

Unknown

Last updated

2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

An abnormal Pap smear result. Diagnosed as ASC-US+HR-HPV, LSIL+HR-HPV or HSIL. Urological and Genital Diseases Abnormal Pap smear result

Interventions

Participants who have an abnormal Pap smear are consecutively recruitment from a womens health clinic. Participants are allocated to one of two groups. Those in the intervention group receive their re

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women aged 23–65-years old 2. Diagnosed with ASC-US + HR-HPV, or LSIL + HR-HPV, or HSIL

Exclusion criteria

Exclusion criteria: Diagnosed with cervical cancer.

Design outcomes

Primary

Measure	Time frame
1. Satisfaction with the notification manner regarding their test result is measured using the self-administrated questionnaire at week one 2. Health related quality of life is measured using the Functional Assessment of Chronic Illness Therapy-Cervical Dysplasia (FACIT-CD) and the Hospital Anxiety and Depression Scale (HADS) at week one	—

Secondary

Measure	Time frame
There are no secondary outcome measures.	—

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026